Skip to main content

Reblozyl Prices, Coupons and Patient Assistance Programs

Reblozyl (luspatercept) is a member of the miscellaneous erythropoiesis agents drug class and is commonly used for Anemia, Beta Thalassemia, and Myelodysplastic Syndrome.

The cost for Reblozyl subcutaneous powder for injection aamt 25 mg is around $3,932 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Reblozyl prices

Subcutaneous Powder For Injection

Reblozyl Coupons, Copay Cards and Rebates

Reblozyl offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Reblozyl BMS Oncology Co-pay Assistance Program

Eligible commercially insured patients' co-pay may be reduced to $0 per dose with savings of up to $10,000 per calendar year; enrollment period is 1 calendar year; for additional information contact the program at 800-861-0048.

Applies to:
Number of uses:
per prescription per calendar year
December 31, 2023

Form more information phone: 800-861-0048 or Visit website

Patient Assistance & Copay Programs for Reblozyl

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Bristol Myers Squibb (BMS) Access Support

Eligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or Puerto Rico
  5. *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please refer to the Enrollment Form to ensure the correct Fax number and address is used for your medication.
Applicable drugs:
  • Reblozyl (luspatercept-aamt) Injection; Subcutaneous

More information please phone: 800-861-0048 Visit Website